Health
$160,000 drug for multiple myeloma blood cancer added to PBS at a cost to patients of $480 – The New Daily
More than 1000 patients with an incurable blood cancer are expected to benefit from a “completely new” treatment subsidised by the federal government.
More than 1000 patients with an incurable type of blood cancer are expected to benefit from a “completely new” treatment that will be subsidised by the federal government in the new year.
Darzalex, which will be listed on the Pharmaceutical Benefits Scheme (PBS) from January 1, is a medicine used to treat multiple myeloma, a cancer that causes cancerous plasma cells to accumulate in bone marrow and crowd out healthy blood cells.
An estimated 18,000 to 20,000 people are living with multiple myeloma…
-
General13 hours agoMore buses without dedicated lanes likely after Gold Coast light rail plan scrapped
-
Business19 hours agoBuy this monthly high-yield ETF instead
-
Noosa News18 hours agoClive Palmer’s lawyer Sam Iskander ‘misplaced’ $2.5m in gold bullion, court told
-
Business17 hours agoThis artificial intelligence (AI) stock could be the Nvidia of quantum computing